Penny Stocks

The Chapter 7 proceedings for Athersys, the developer behind MultiStem, are entering their tail end in a U.S. bankruptcy court...

Atreca, the biotechnology firm, is in the final phase of its wind-down and formal dissolution. Shareholders had already endorsed this...

Investors holding shares of Novan have reached the end of the line. The company's stock is now effectively worthless, a...

Investors sent shares of SunHydrogen sharply higher following a significant corporate announcement. The company revealed it has finalized a definitive...

Biotechnology firm Rallybio is navigating a significant operational transition. Having recently adjusted its capital structure to secure its stock exchange...

A quiet period at Elys Game Technology has left market participants looking elsewhere for signals, even as the broader sports...

The bankruptcy proceedings for specialty retailer Conn's have entered their conclusive stage, sealing the fate of its equity holders. With...

Chicken Soup for the Soul Entertainment has reached the terminal stage of its corporate existence. The company, which filed for...

Following the failure of its lead clinical candidate, Quince Therapeutics has initiated a formal review of its strategic options. The...

As Singularity Future Technology prepares to release its latest financial figures, investor attention is turning to the company's ongoing transition....